{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:00Z","timestamp":1786988040245,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejca.2026.116825","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:18:25Z","timestamp":1779466705000},"page":"116825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trial"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5090-4935","authenticated-orcid":false,"given":"Philip","family":"Heesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Feuerriegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ciobanu-Caraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ranft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Bhadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Brichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Collaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Cyprova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Eich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0518-983X","authenticated-orcid":false,"given":"Torben","family":"Ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Gelderblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8408-2255","authenticated-orcid":false,"given":"Jendrik","family":"Hardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8519-8906","authenticated-orcid":false,"given":"Lianne","family":"Haveman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Kanerva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7387-7028","authenticated-orcid":false,"given":"Thomas","family":"K\u00fchne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Raciborska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-6943","authenticated-orcid":false,"given":"Jelena","family":"Rascon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Streitb\u00fcrger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Uhlenbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6453-3947","authenticated-orcid":false,"given":"Bruno","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Dirksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116825_bib1","unstructured":"WHOWHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. WHO Classification of Tumours; 2020.."},{"issue":"1","key":"10.1016\/j.ejca.2026.116825_bib2","first-page":"1","article-title":"Ewing sarcoma","volume":"4","author":"Gr\u00fcnewald","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejca.2026.116825_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113260","article-title":"Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial","volume":"192","author":"Heesen","year":"2023","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116825_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijrobp.2004.02.001","article-title":"Late effects of radiotherapy for pediatric extremity sarcomas","volume":"60","author":"Paulino","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ejca.2026.116825_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/COC.0000000000000176","article-title":"Long-term outcomes and complications in pediatric Ewing Sarcoma","volume":"40","author":"Hamilton","year":"2017","journal-title":"Am J Clin Oncol"},{"issue":"23","key":"10.1016\/j.ejca.2026.116825_bib6","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.3390\/cancers14235920","article-title":"Secondary malignancies after Ewing sarcoma-epidemiological and clinical analysis of an international trial registry","volume":"14","author":"Kaiser","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.ejca.2026.116825_bib7","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/cncr.35196","article-title":"Radiation therapy dose escalation achieves high rates of local control with tolerable toxicity profile in pediatric and young adult patients with Ewing sarcoma","volume":"130","author":"Kacar","year":"2024","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.ejca.2026.116825_bib8","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/1078-0432.CCR-23-1966","article-title":"Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial","volume":"29","author":"Koch","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"21","key":"10.1016\/j.ejca.2026.116825_bib9","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1200\/JCO.21.01942","article-title":"High-dose treosulfan and melphalan as consolidation therapy versus standard therapy for high-risk (metastatic) Ewing sarcoma","volume":"40","author":"Koch","year":"2022","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.ejca.2026.116825_bib10","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1200\/JCO.19.00915","article-title":"High-dose chemotherapy compared with standard chemotherapy and lung radiation in Ewing sarcoma with pulmonary metastases: Results of the European Ewing tumour working initiative of national groups, 99 trial and EWING 2008","volume":"37","author":"Dirksen","year":"2019","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116825_bib11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41591-024-02902-1","article-title":"Causal machine learning for predicting treatment outcomes","volume":"30","author":"Feuerriegel","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116825_bib12","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-3668","article-title":"The predictive approaches to treatment effect heterogeneity (PATH) statement: explanation and elaboration","volume":"172","author":"Kent","year":"2020","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.ejca.2026.116825_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/AIp2500277","article-title":"Opportunities for causal machine learning in precision oncology","volume":"2","author":"Weberpals","year":"2025","journal-title":"NEJM AI"},{"issue":"2","key":"10.1016\/j.ejca.2026.116825_bib14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/CORR.0000000000000962","article-title":"Which factors are associated with local control and survival of patients with localized pelvic Ewing\u2019s sarcoma? A retrospective analysis of data from the Euro-EWING99 trial","volume":"478","author":"Andreou","year":"2020","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ejca.2026.116825_bib15","unstructured":"Vegetabile B.G.On the distinction between \u201cconditional average treatment effects\u201d (CATE) and \u201cindividual treatment effects\u201d (ITE) under ignorability assumptions. arXiv [statME]. Published online August 10, 2021. http:\/\/arxiv.org\/abs\/2108.04939."},{"key":"10.1016\/j.ejca.2026.116825_bib16","doi-asserted-by":"crossref","unstructured":"Cui Y., Kosorok M.R., Sverdrup E., Wager S., Zhu R.Estimating heterogeneous treatment effects with right-censored data via causal survival forests. J R Stat Soc Series B Stat Methodol. Published online February 27, 2023. doi:10.1093\/jrsssb\/qkac001.","DOI":"10.1093\/jrsssb\/qkac001"},{"issue":"2","key":"10.1016\/j.ejca.2026.116825_bib17","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1214\/18-AOS1709","article-title":"Generalized random forests","volume":"47","author":"Athey","year":"2019","journal-title":"Ann Stat"},{"key":"10.1016\/j.ejca.2026.116825_bib18","doi-asserted-by":"crossref","unstructured":"Ishwaran H., Kogalur U.B., Blackstone E.H., Lauer M.S.Random survival forests. arXiv [statAP]. Published online November 11, 2008. http:\/\/arxiv.org\/abs\/0811.1645.","DOI":"10.1214\/08-AOAS169"},{"issue":"14","key":"10.1016\/j.ejca.2026.116825_bib19","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2024.3376","article-title":"Using effect scores to characterize heterogeneity of treatment effects","volume":"331","author":"Wang","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2026.116825_bib20","unstructured":"Yadlowsky S., Fleming S., Shah N., Brunskill E., Wager S.Evaluating treatment prioritization rules via rank-weighted average treatment effects. arXiv [statME]. Published online November 15, 2021. http:\/\/arxiv.org\/abs\/2111.07966."},{"key":"10.1016\/j.ejca.2026.116825_bib21","unstructured":"Lundberg S., Lee S.I.A unified approach to interpreting model predictions. arXiv [csAI]. Published online May 22, 2017. http:\/\/arxiv.org\/abs\/1705.07874."},{"issue":"10","key":"10.1016\/j.ejca.2026.116825_bib22","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.1804597116","article-title":"Metalearners for estimating heterogeneous treatment effects using machine learning","volume":"116","author":"K\u00fcnzel","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2026.116825_bib23","unstructured":"Athey S., Imbens G.Recursive partitioning for heterogeneous causal effects. arXiv [statML]. Published online April 5, 2015. Accessed June 15, 2025. https:\/\/gsb-faculty.stanford.edu\/guido-w-imbens\/files\/2022\/04\/3350.pdf."},{"key":"10.1016\/j.ejca.2026.116825_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jclinepi.2015.04.005","article-title":"Prediction models need appropriate internal, internal\u2013external, and external validation","volume":"69","author":"Steyerberg","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejca.2026.116825_bib25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R","article-title":"Multiple imputation of missing blood pressure covariates in survival analysis","volume":"18","author":"Van Buuren","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2026.116825_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2016.03.075","article-title":"Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group","volume":"61","author":"Foulon","year":"2016","journal-title":"Eur J Cancer"},{"issue":"9454","key":"10.1016\/j.ejca.2026.116825_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(05)17709-5","article-title":"Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2026.116825_bib28","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp068070","article-title":"The challenge of subgroup analyses -- reporting without distorting","volume":"354","author":"Lagakos","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejca.2026.116825_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S1470-2045(24)00259-6","article-title":"Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study","volume":"25","author":"Bertsimas","year":"2024","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116825_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jso.24652","article-title":"Does surgery or radiation provide the best overall survival in Ewing\u2019s sarcoma? A review of the national cancer data base","volume":"116","author":"Miller","year":"2017","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116825_bib31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0360-3016(02)03797-5","article-title":"Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials","volume":"55","author":"Schuck","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejca.2026.116825_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41746-020-0221-y","article-title":"An overview of clinical decision support systems: benefits, risks, and strategies for success","volume":"3","author":"Sutton","year":"2020","journal-title":"NPJ Digit Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926006064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926006064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:48:14Z","timestamp":1783486094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926006064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":32,"alternative-id":["S0959804926006064"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116825","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116825"}}